Featured Research

from universities, journals, and other organizations

New path for novel Alzheimer's therapies

Date:
May 22, 2010
Source:
Elhuyar Fundazioa
Summary:
Researchers have found a new Alzheimer's-related mechanism that could give rise to the development of new therapies against this disease.

Researchers from the University of the Basque Country (UPV/EHU) have found a new Alzheimer's-related mechanism that could give rise to the development of new therapies against this disease.

Related Articles


The study was recently published in the journal Cell Calcium, and the authors have already applied for a European patent to protect the commercial exploitation of this new discovery.

The novelty lies in a new mechanism through which the amyloid peptide, the major pathogen in Alzheimer's disease, provokes neuronal death. The Basque researchers have found that this peptide activates some receptors that lead cells to overexcitation and subsequent death; when such receptors are blocked with specific drugs, neurons are protected from the peptide-related lethal effects. This finding is particularly relevant for the development of new therapies slowing down Alzheimer's progression.

The research work was supervised by Dr. Carlos Matute, Director of Neurotek research centre and Head of the Neurobiology Laboratory of the Neurosciences Department at the University of the Basque Country (UPV/EHU). The research team led by Dr. Matute deals with the molecular and cell fundamentals of neurodegenerative diseases such as Alzheimer's or multiple sclerosis. In particular, it focuses on the mechanism leading to cell death in the nervous system by using different tests based on cell cultures, experimental animals, human brains coming from demised people suffering these diseases and living patients' samples.

This team, which has already released many patents, also searches for markers supporting early diagnosis of these diseases.


Story Source:

The above story is based on materials provided by Elhuyar Fundazioa. Note: Materials may be edited for content and length.


Journal Reference:

  1. Elena Alberdi, Mª Victoria Sánchez-Gómez, Fabio Cavaliere, Alberto Pérez-Samartín, José Luis Zugaza, Ramón Trullas, María Domercq, Carlos Matute. Amyloid β oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium, 2010; 47 (3): 264 DOI: 10.1016/j.ceca.2009.12.010

Cite This Page:

Elhuyar Fundazioa. "New path for novel Alzheimer's therapies." ScienceDaily. ScienceDaily, 22 May 2010. <www.sciencedaily.com/releases/2010/05/100520093030.htm>.
Elhuyar Fundazioa. (2010, May 22). New path for novel Alzheimer's therapies. ScienceDaily. Retrieved April 18, 2015 from www.sciencedaily.com/releases/2010/05/100520093030.htm
Elhuyar Fundazioa. "New path for novel Alzheimer's therapies." ScienceDaily. www.sciencedaily.com/releases/2010/05/100520093030.htm (accessed April 18, 2015).

Share This


More From ScienceDaily



More Mind & Brain News

Saturday, April 18, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Our Love Of Puppy Dog Eyes Explained By Science

Our Love Of Puppy Dog Eyes Explained By Science

Newsy (Apr. 17, 2015) — Researchers found a spike in oxytocin occurs in both humans and dogs when they gaze into each other&apos;s eyes. Video provided by Newsy
Powered by NewsLook.com
Scientists Find Link Between Gestational Diabetes And Autism

Scientists Find Link Between Gestational Diabetes And Autism

Newsy (Apr. 17, 2015) — Researchers who analyzed data from over 300,000 kids and their mothers say they&apos;ve found a link between gestational diabetes and autism. Video provided by Newsy
Powered by NewsLook.com
Video Messages Help Reassure Dementia Patients

Video Messages Help Reassure Dementia Patients

AP (Apr. 17, 2015) — Family members are prerecording messages as part of a unique pilot program at the Hebrew Home in New York. The videos are trying to help victims of Alzheimer&apos;s disease and other forms of dementia break through the morning fog of forgetfulness. (April 17) Video provided by AP
Powered by NewsLook.com
Common Pain Reliever Might Dull Your Emotions

Common Pain Reliever Might Dull Your Emotions

Newsy (Apr. 16, 2015) — Each week, millions of Americans take acetaminophen to dull minor aches and pains. Now researchers say it might blunt life&apos;s highs and lows, too. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins